| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 1372591 | Bioorganic & Medicinal Chemistry Letters | 2011 | 4 Pages |
Abstract
To obtain information on the pharmacophoric requirements of the CB1/CB2 partial agonist BAY 59–3074 we have synthesized a series of new conformationally constrained dibenzofuran (4a–d) and dibenzopyran analogs (5). All constrained analogs exhibited reduced binding affinity at both cannabinoid receptor subtypes, suggesting that planar conformations of these ligands are less favored by both receptors. We also found that 4c, 4d, and 5 exhibited 3- to 12-fold selectivity for hCB2 over rCB1 receptors and may serve as new chemotypes for the development of CB2-selective cannabinergics.
Graphical abstractFigure optionsDownload full-size imageDownload as PowerPoint slide
Keywords
Related Topics
Physical Sciences and Engineering
Chemistry
Organic Chemistry
Authors
Heidi Teng, Ganesh A. Thakur, Alexandros Makriyannis,
